Balance
Balance, licence 80097549: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Plexus Canada Limited Partnership dba Plexus Worldwide
- NPN or DIN-HM
- 80097549
- Status
- Inactive licence
- Licence date
- 11 March 2020
- Revision date
- 28 April 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Extrait de haricot blanc Source : Phaseolus vulgaris - Graine Extract : Matériel brut sec Extraction ratio : 12:1 Dry plant equivalent : 4.5 g | 375.0 mg | Not calculated |
| Extrait de haricot blanc Source : Phaseolus vulgaris - Graine | 1125.0 AAIU | Not calculated |
| Cinnamomum aromaticum Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 0.5 g Potency : 10.0 % Polyphenols | 50.0 mg | Not calculated |
| Extrait de haricot blanc Source : Phaseolus vulgaris - Graine | 27500.0 AAIU | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Hypromellose, Dioxyde de silicium, Huile de tournesol, Phosphate dicalcique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
Uses authorised in Canada
Provides support for healthy (postprandial) glucose metabolism. Helps improve (postprandial) glucose metabolism. Helps reduce the (enzymatic) digestion of carbohydrates. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are breastfeeding or have diabetes, or for use beyond 12 weeks. Do not use this product if you are pregnant. Stop use if hypersensitivity/allergy occurs.
Source
Official Health Canada record, licence 80097549
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.